This trial will test the impact of a reading intervention program on children with ASD to see if it changes the neurobiological mechanisms underlying reading comprehension deficits.
- Autism Spectrum Disorder (ASD)
- Autism Spectrum Disorder
- Autism Spectrum Disorder with Neuropsychiatric Symptoms (ASD-NPS)
2 Primary · 1 Secondary · Reporting Duration: 10-12 weeks
Awards & Highlights
2 Treatment Groups
ASD-WLC and NT
1 of 2
ASD-EXP and NT-EXP
1 of 2
200 Total Participants · 2 Treatment Groups
Primary Treatment: ASD-EXP and NT-EXP · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 7 - 13 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the protocol for this clinical trial allow those of advanced age to participate?
"Based on the parameters of this study, participants must fall between 7 and 13 years old." - Anonymous Online Contributor
How many individuals have registered to partake in this experiment?
"Affirmative. The clinical trial data found on clinicaltrials.gov shows that the research is actively seeking participants, with a starting date of January 10th 2019 and most recent update occurring on September 30th 2022. 200 people are required from 1 centre to complete the study." - Anonymous Online Contributor
Are there still openings for participants in this experiment?
"According to the records on clinicaltrials.gov, this medical experiment is currently seeking patients and has been since January 10th 2019. The last update was made on September 30th 2022." - Anonymous Online Contributor
What qualifications must an individual possess to be eligible for this investigation?
"This clinical study aims to recruit two hundred children, ranging from 7-13 years of age and diagnosed with autism spectrum disorder. Furthermore, participants must adhere to several criteria in order for eligibility: no stimulants within 24 hours prior, absence of antipsychotics treatment for one month minimum, lack of antiepileptics/convulsants use over the last week; meet American Psychiatric Association's DSM-V standards (2013); Full Scale IQs score higher than 70 and possess similar reading comprehension difficulties as ASD patients but featuring average decoding complemented by below standard reading understanding." - Anonymous Online Contributor